Sleep Extension
Conditions
Brief summary
Emerging evidence suggests that approximately 30% of the US adult population sleeps less than 7 hours per night, and those who do exhibit 20-52% enhanced risk to develop cardiovascular diseases and particularly hypertension. Since sleep curtailment is largely voluntary, sleep deficiency can be corrected and its detrimental health consequences potentially reversed. The purpose of the present proposal is to investigate the cardiovascular and metabolic effects of sleep extension in prehypertensive and stage 1 hypertensive subjects who report habitual short sleep.
Interventions
BEHAVIORALsleep extension
BEHAVIORALsleep maintenance
Sponsors
Mayo Clinic
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Age: 18 to 65 (inclusive) * Gender: both males and females * Body mass index (BMI): 18.5-34.9 kg/m2 * Habitual sleep duration: \<7 hours * Presence of either: * Prehypertension: office systolic BP (SBP) 120-139 mmHg and/or diastolic BP (DBP) 80- 89 mmHg; * Stage 1 hypertension: office SBP 140-159 mmHg and/or DBP 90-99 mmHg * Either on no prescription medications (other than oral contraceptive pills, or intrauterine devices) or on stable medical regimen for at least 1 month, if taking prescription medications for chronic conditions * Not pregnant or breast feeding and not intending to become pregnant or breast feed * Not a current smoker or tobacco user * Ability to provide written informed consent
Exclusion criteria
* Vulnerable study populations will be excluded * Pregnancy * Smoking * Presence of overt cardiovascular diseases, diabetes, chronic kidney disease, cancer, sleep disorders, psychiatric disorders * If taking prescription medications for chronic conditions, change in therapy (type, frequency and/or dosage) over the previous month * Habitual sleep duration ≥7 hours * Excessive alcohol (≥15 drinks/week in men and ≥8 drinks/week in women) and/or excessive caffeine intake (\>400 mg) * Currently on a diet and/or actively trying to lose weight * Currently or previously (during the past 2 months) participation in any other research study at the discretion of study personnel * Blood/plasma donation during the past 2 months * Unwillingness or inability to adjust sleep schedule.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| change in 24-hour mean arterial pressure | 8 weeks |
Secondary
| Measure | Time frame |
|---|---|
| change in baroreflex sensitivity | 8 weeks |
| change in endothelial function | 8 weeks |
| change in insulin sensitivity | 8 weeks |
Countries
United States
Outcome results
None listed